A carregar...

Gene therapy for primary immune deficiencies: a Canadian perspective

The use of gene therapy (GT) for the treatment of primary immune deficiencies (PID) including severe combined immune deficiency (SCID) has progressed significantly in the recent years. In particular, long-term studies have shown that adenosine deaminase (ADA) gene delivery into ADA-deficient hematop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Allergy Asthma Clin Immunol
Main Authors: Xu, Xiaobai, Tailor, Chetankumar S., Grunebaum, Eyal
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5327566/
https://ncbi.nlm.nih.gov/pubmed/28261277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-017-0184-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!